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Pafety of Dobutamine Stress
eal-Time Myocardial Contrast Echocardiography
eane M. Tsutsui, MD, Abdou Elhendy, MD, FACC, Feng Xie, MD, Edward L. O’Leary, MD, FACC,
nna C. McGrain, RN, BSN, Thomas R. Porter, MD, FACC
maha, Nebraska
OBJECTIVES The aim of this study was to determine the safety of dobutamine stress myocardial perfusion
imaging (MPI) obtained by real-time contrast echocardiography (RTCE) and intravenous
ultrasound contrast in a large cohort of patients with suspected coronary artery disease
(CAD).
BACKGROUND Despite the increasing number of studies showing the potential clinical utility of myocardial
contrast perfusion imaging with commercially available contrast agents, the safety of this
technique in a clinical setting has not been demonstrated.
METHODS Over a four-year period, 1,486 patients underwent dobutamine stress RTCE with low
mechanical index pulse sequence schemes after intravenous injections of commercially
available contrast agents (35% Definity, Bristol Myers Squibb Medical Imaging Inc., North
Billerica, Massachusetts; 65% Optison, GE-Amersham, Princeton, New Jersey). The
hemodynamic and adverse effects of RTCE were compared with 1,012 patients who
underwent conventional dobutamine stress echocardiography (DSE) without contrast. The
feasibility of image analysis was defined as the ability to analyze MPI in at least two of the
three standard segments in each left ventricular wall.
RESULTS No myocardial infarction or death occurred during dobutamine stress. There was no
difference in the incidence of nonsustained ventricular tachycardia, sustained ventricular
tachycardia, or supraventricular tachycardia during dobutamine infusion between RTCE and
DSE. Myocardial perfusion imaging was considered feasible for analysis in 94% of the walls
at baseline and 95% at peak stress. The anterior, lateral, and posterior walls were the most
common regions in which MPI was not feasible. Myocardial perfusion imaging with RTCE
had a higher accuracy for detecting patients with angiographically significant CAD than the
analysis of wall motion (84% vs. 66%, respectively; p  0.001).
CONCLUSIONS Dobutamine stress RTCE appears to be a safe and feasible technique for evaluating patients
with known or suspected CAD. (J Am Coll Cardiol 2005;45:1235–42) © 2005 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.01.024American College of Cardiology Foundation
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pobutamine stress echocardiography (DSE) is a widely
sed technique for the assessment of patients with known or
uspected coronary artery disease (CAD). Over the last 10
ears, several studies have confirmed its safety and effective-
ess for the diagnostic and prognostic evaluation of different
atient populations (1–4). Myocardial contrast echocardi-
graphy has been proven useful for the assessment of
yocardial perfusion after intravenous injections or infu-
ions of ultrasound contrast agents (5,6). Real-time contrast
chocardiography (RTCE) is a recently developed tech-
ique that utilizes a low mechanical index causing minimal
icrobubble destruction (7–9). Real-time contrast echocar-
iography is particularly advantageous over intermittent
armonic imaging techniques when the simultaneous eval-
ation of myocardial perfusion imaging (MPI) and wall
otion is necessary, such as during DSE.
The analysis of MPI with RTCE has been shown, in
tudies with relatively small numbers of patients, to improve
he sensitivity of DSE in detecting significant CAD (7,10).
From the Department of Internal Medicine, Section of Cardiology, University of
ebraska Medical Center, Omaha, Nebraska. Grant support provided by Bristol
yers Squibb Medical Imaging. Dr. Porter has a conflict of interest which is Bristol
yers Squibb Medical Imaging.h
Manuscript received November 3, 2004; revised manuscript received December 9,
004; accepted January 4, 2005.owever, the Food and Drug Administration (FDA) has
ot formally approved the use of intravenous ultrasound
ontrast agents to detect myocardial perfusion, and recent
tudies have raised concerns regarding unwanted bioeffects
elated to ultrasound-induced microbubble destruction (11–
3). Specifically, during DSE, there may be concerns about
otentiation of cardiac arrhythmias. The aims of this study
ere to determine the safety of dobutamine stress RTCE in
large number of patients with suspected or known CAD
nd to compare the safety profile of RTCE with the
onventional DSE profile.
ETHODS
atients. From January 2000 to January 2004 we studied
,498 patients with known or suspected CAD referred for a
obutamine stress test. Among them, 1,486 patients under-
ent RTCE with the analysis of wall motion and MPI after
ntravenous injections of commercially available contrast
gents at rest and during dobutamine stress. The analysis of
ata from these studies was approved by the Institutional
eview Board of the University of Nebraska Medical
enter, and all patients gave informed consent to partici-
ate. The exclusion criteria observed were: age 18 years,
emodynamic instability, unstable angina, recent myocar-
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Safety of Myocardial Contrast Perfusion Imaging April 19, 2005:1235–42ial infarction, and contraindications to any drug used in the
rotocol (14). The incidence of arrhythmias, adverse effects,
nd hemodynamic data of these 1,486 patients were com-
ared with those of 1,012 patients who underwent conven-
ional DSE without contrast agents in the same time period
t our institute. The selection of patients to undergo
ontrast versus noncontrast DSE studies was based on the
reference and experience of the attending physician, and
ot on a patient’s pre-test probability for CAD or echocar-
iographic windows. The clinical characteristics of both
roups are described in Table 1.
tudy protocol. For all stress protocols, patients were gener-
lly instructed to discontinue beta-blockers at least 24 h before
he stress test. Dobutamine was infused intravenously at a
tarting dose of 5 g/kg/min, followed by increasing doses of
0, 20, 30, 40, up to a maximal dose of 50 g/kg/min, in 3- to
-min stages (2). Atropine (up to 2.0 mg) was injected in
atients without symptoms or signs of myocardial ischemia not
chieving 85% of the age-predicted maximal heart rate, calcu-
ated as 220 age in years. The contrast agents used were the
ommercially available albumin-encapsulated microbubble
ptison (GE-Amersham, Princeton, New Jersey) or the lipid-
ncapsulated microbubble Definity (Bristol-Myers Squibb
edical Imaging Inc., North Billerica, Massachusetts). The
oses of contrast used for the assessment of MPI were the same
Abbreviations and Acronyms
CAD  coronary artery disease
DSE  dobutamine stress echocardiography
FDA  Food and Drug Administration
LV  left ventricular
MPI  myocardial perfusion imaging
PVC  premature ventricular complexes
RTCE  real-time contrast echocardiography
WMA  wall motion abnormalities
able 1. Patient Demographics in the RTCE and in the
onventional DSE
Variables
RTCE
(n  1,486)
DSE
(n  1,012)
ge (yrs) 62  14 63  13
ale gender 756 (51%) 431 (43%)*
eight (kg) 87  23 86  23
iabetes mellitus 508 (34%) 263 (26%)*
yslipidemia 669 (45%) 493 (49%)
ypertension 933 (63%) 702 (69%)*
igarette smoking 499 (34%) 315 (31%)
revious myocardial infarction 220 (15%) 109 (11%)*
revious coronary bypass surgery 162 (11%) 81 (8%)*
revious percutaneous coronary
intervention
166 (11%) 108 (11%)
eta-blockers 633 (43%) 430 (42%)
alcium channel blockers 308 (21%) 202 (20%)
itrates 199 (13%) 127 (12%)
eft ventricular ejection fraction (%) 60  11 59  10
ata are mean  SD and number (%) of patients. *p  0.05 between groups.l
DSE  dobutamine stress echocardiography; RTCE  real-time contrast echo-
ardiography.oses recommended for enhancement of the left ventricular
LV) border delineation during stress testing (15). Optison was
njected in bolus doses of 0.2 to 0.3 ml and Definity in a bolus
f 0.1 ml, followed by a 3 to 5 ml saline flush.
Blood pressure and cardiac rhythm were monitored
ontinuously before and during the dobutamine infusion.
welve-lead electrocardiograms were obtained at three-min
ntervals. End-points of the stress test were: achievement of
he target heart rate (85% of predicted maximal heart rate),
aximal dobutamine/atropine doses, development of severe
r extensive wall motion abnormalities (WMA), ST-
egment elevation0.1 mV at an interval of 80 ms after the
point in non–Q-wave leads, sustained arrhythmias, severe
hest pain, or intolerable side effects (14). The tests were
onsidered diagnostic if the target heart rate and/or an
schemic end point were achieved (WMA or perfusion
efects). The tests were considered nondiagnostic if the
atient failed to achieve the target heart rate without
nducible ischemia.
mage acquisition. Real-time contrast echocardiography
as performed using the commercially available ultrasound
canners HDI 5000 in 868 (58%) patients (Philips Medical
ystems, Bothell, Washington), Sonos 5500 in 381 (26%)
atients (Philips Medical Systems), or Sequoia 6.0 in 237
16%) patients (Siemens Acuson, Mountain View, Califor-
ia). Each was equipped with low mechanical index real-
ime pulse sequence schemes, which deploy pulses of alter-
ating polarity and/or amplitude. Each system was adjusted
o achieve optimal nonlinear signal at a mechanical index
0.3 and frame rate 25 Hz. Time gain compensation and
wo-dimensional gain settings were adjusted to suppress any
onlinear signals from tissue before contrast injection.
quipment settings were then kept unchanged throughout
he study. Contrast-enhanced images were obtained in the
pical four-chamber, two-chamber, and three-chamber
iews at baseline, at low doses of dobutamine if resting
MA were present, at intermediate stage when 70% of the
redicted maximal heart rate was achieved, and at peak
tress as previously defined. The RTCE images were digi-
ally acquired after peak myocardial opacification until
isappearance of contrast from the myocardium. No high
echanical index frames (mechanical index 0.6) were
pplied when myocardial contrast was present.
In the conventional DSE without contrast protocol,
wo-dimensional images were obtained with the same ul-
rasound machines using second-harmonic imaging at a
igh mechanical index. The standard echocardiographic
iews (parasternal long and short axis, apical four-, two-,
nd three-chamber) were acquired at the same stages as
escribed in RTCE. All images were recorded on videotape
nd digitized in continuous loop format for side-by-side
nalysis.
mage analysis. Both the contrast-enhanced wall motion
nd the myocardial perfusion were evaluated during the
obutamine stress RTCE by an experienced observer. Theeft ventricle was divided in 17 segments according to the
r
r
d
c
w
p
M
s
c
o
a
m
P
p
W
n
W
t
fi
W
o
c
c
i
c
i
8
(
S
d
R
v
v
c
m
p
d
s

d
a
w
r
h
d
a
D
b
f
u
s
c
w
a
p
e
g
t
v
e
w
w
d
r
d
F
o
w
d
t
p
o
c
e
v
r
m
t
a
o
a
l
w
T
a
p
a
a
c
S
a
p
w
t
t
n
D
v
a
t
r
p
c
R
A
w
d
5
1237JACC Vol. 45, No. 8, 2005 Tsutsui et al.
April 19, 2005:1235–42 Safety of Myocardial Contrast Perfusion Imagingecommendations of the American Society of Echocardiog-
aphy (16). Myocardial perfusion imaging was analyzed
uring a 15-s period that typically appeared after each
ontrast injection. Using the wall motion criteria, the test
as defined as positive if there were new or worsening of
re-existing WMA in 2 contiguous segments (14). The
PI results were considered abnormal if 2 contiguous
egments failed to exhibit contrast enhancement (subendo-
ardial or transmural) at peak stress when compared with
ther segments at the same depth in the same view, as well
s compared with contrast enhancement in the same seg-
ents at baseline using a side-by-side image analysis.
atients with normal wall motion both at baseline and at
eak stress were classified as having a negative study for
MA. Patients with normal wall motion at baseline and
ew WMA at peak stress were classified as having inducible
MA. Patients with WMA at baseline that did not change
hroughout dobutamine infusion were classified as having
xed WMA. Those studies in which there were resting
MA that did not change but in which new WMA in
ther segments did occur during dobutamine infusion were
haracterized as having fixed plus inducible WMA. The
lassification of normal, inducible, fixed, and fixed plus
nducible MPI abnormalities was performed using the same
riteria as for WMA. The interobserver agreement for the
nterpretation of perfusion with RTCE in our laboratory is
4% (Kappa  0.63) and 91% for wall motion analysis
Kappa  0.64) (7).
afety of RTCE. The adverse effects that occurrred during
obutamine stress were evaluated in patients who received
TCE with Optison, RTCE with Definity, and the con-
entional DSE without contrast. The presence of premature
entricular complexes (PVC), premature supraventricular
omplexes, and any other cardiac arrhythmias was deter-
ined by reviewing the 12-lead electrocardiograms of all
atients acquired at baseline and during each stage of
obutamine infusion. Hypotension was defined as a fall of
ystolic blood pressure below 80 mm Hg or a reduction
40 mm Hg from baseline. A hypertensive response was
efined as blood pressure 230/120 mm Hg (1). Minor
dverse effects were defined as those that were self-limited,
hich responded promptly to dobutamine infusion inter-
uption or metoprolol administration, and did not require
ospital admission, whereas major adverse effects were
efined as those that led to a new hospital admission as well
s death and myocardial infarction (2).
iagnostic accuracy of RTCE. The diagnostic accuracy of
oth the wall motion analysis and MPI obtained by RTCE
or detecting CAD was determined in 249 patients who
nderwent coronary angiography within one month of the
tress test. Wall motion and MPI were analyzed on a
oronary artery territory basis by one independent reviewer
ho was blinded to the results of the angiogram. Coronary
ngiography was performed at the discretion of the referring
hysician. Patients with an intervening cardiac event were
xcluded from this analysis. Quantitative coronary angio- 0raphic analysis was performed by an experienced interven-
ional cardiologist unaware of the results of RTCE. Any
isually evident stenosis was measured using a hand-held
lectronic caliper (Tesa S.A., Renes, Switzerland) operated
ith custom-developed PC software (17). Measurements
ere expressed as the percent diameter narrowing using the
iameter of the nearest normal-appearing region as the
eference. Significant CAD was defined as 50% luminal
iameter stenosis in 1 major coronary artery.
easibility of RTCE image interpretation. The feasibility
f MPI image interpretation was determined for each LV
all and for each coronary artery territory (left anterior
escending, left circumflex, and right coronary artery terri-
ories) in 524 randomly chosen patients (35% of the entire
opulation). Feasibility was determined by an experienced
bserver blinded to the initial test results. Attenuation from
ontrast or lung interference was defined as present if the
ndocardial and epicardial borders of a segment could not be
isualized and, thus, were not distinguishable from sur-
ounding tissues (7).
Analysis of MPI was deemed feasible in a wall if
yocardial contrast enhancement was analyzable in at least
wo of three segments of each wall (septal, lateral, inferior,
nterior, posterior, and anteroseptal walls). For the purpose
f coronary artery territory analysis, the LV apex, the
nteroseptal, and the anterior walls were attributed to the
eft anterior descending artery. The lateral and posterior
alls were assigned to the left circumflex artery territory.
he inferior and basal to mid segments of the septum were
ssigned to the right coronary artery territory. Myocardial
erfusion imaging was considered feasible in the coronary
rtery territory when at least one of the walls could be
nalyzed for MPI according to the previously described
riteria.
tatistical analysis. Continuous variables were expressed
s mean and standard deviation, and categorical variables as
roportions. Two-tailed unpaired and paired Student t tests
ere used for inter- and intragroup comparisons, respec-
ively. Chi-square test was used for comparisons of propor-
ions. Analysis of variance was used to compare hemody-
amic data between RTCE with Optison, RTCE with
efinity, and DSE. The sensitivity, specificity, predictive
alues, and accuracy of wall motion and MPI for detecting
ngiographically significant CAD were calculated according
o standard definitions and were presented with their
espective 95% confidence intervals. All data analysis was
erformed with SPSS 11.0 for Windows (SPSS Inc. Chi-
ago, Illinois). A p value 0.05 was considered significant.
ESULTS
mong the 1,486 patients who underwent RTCE, Optison
as used in 963 (65%) patients using a mean cumulative
ose of 2.8  0.8 ml. Definity was used in the remaining
23 (35%) patients using a mean cumulative dose of 1.0 
.3 ml. The mean peak dose of dobutamine was 32 
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Safety of Myocardial Contrast Perfusion Imaging April 19, 2005:1235–42g/kg/min. Atropine was injected in 1,240 (83%) patients
sing a mean cumulative dose of 0.8  0.6 mg. Patient
eight and body habitus were similar between RTCE and
onventional DSE groups (Table 1).
The analysis of both wall motion and MPI by RTCE was
ompleted in 1,351 (91%) patients, whereas it was consid-
red nondiagnostic in 135 patients. This was due to failure
o reach the target heart rate in 110 (7%) patients, and
ailure to achieve myocardial contrast enhancement in 25
2%) patients.
Among the 1,351 patients with diagnostic dobutamine
tress RTCE, 1,046 (77%) patients had no WMA, 159
12%) had inducible WMA, 85 (6%) had fixed WMA, and
1 (5%) had fixed plus inducible WMA. When analyzing
PI, 861 (64%) patients had no myocardial perfusion
efects, 351 (26%) had inducible myocardial perfusion
efects, 49 (4%) had fixed myocardial perfusion defects, and
0 (6%) had fixed plus inducible myocardial perfusion
efects. Myocardial perfusion imaging was abnormal in a
igher number of patients than WMA, as illustrated in
igure 1. Inducible defects within at least one coronary
rtery territory were identified in 32% of patients by MPI
nd 17% by WMA (p  0.01). All patients with WMA
uring dobutamine stress also exhibited perfusion defects by
TCE.
In the conventional DSE without contrast group, the
oses of dobutamine and atropine used were 33  8
g/kg/min (p  NS vs. RTCE) and 0.6  0.5 mg (p 
.001 vs. RTCE), respectively. The conventional DSE tests
ere diagnostic in 922 (91%) patients. There were 90 (9%)
atients in which the DSE was nondiagnostic, mainly due
o failure to achieve target heart rate. Among the 922
atients with diagnostic DSE without contrast, 769 (83%)
ad no WMA, 68 (8%) had inducible WMA, 59 (6%) had
xed WMA, and 26 (3%) had fixed plus inducible WMA.
afety. Table 2 summarizes the hemodynamic profile ob-
erved in the patients who underwent RTCE with Optison,
TCE with Definity, and conventional DSE. The groups
eached a similar percentage of predicted maximal heart rate
t peak stress, and there were no differences in the heart
ate, blood pressure, or rate-pressure product between
TCE and DSE at peak stress.
The incidence of arrhythmias and other adverse effects
ere similar between the groups (Table 3). Only five (0.3%)
atients in RTCE and three (0.2%) patients in DSE had
entricular tachycardia that required dobutamine interrup-
ion and metoprolol injection. The proportion of patients
ith sustained arrhythmias, which included sustained ven-
ricular tachycardia, atrial fibrillation/flutter, and supraven-
ricular tachycardia, was similar in RTCE with Optison
4.2%), RTCE with Definity (4.0%), and conventional
SE without contrast (3.6%). The groups had similar
ncidences of hypotension, hypertension, and dyspnea.
hest pain at peak dobutamine stress occurred with equalrequency in both the abnormal and normal RTCE and sonventional DSE studies. No myocardial infarction or
eath during dobutamine stress occurred in either group.
iagnostic accuracy of RTCE. As has been described
reviously (10), MPI improved the sensitivity, negative
redictive value, and accuracy for the detection of CAD
hen compared with WMA. The specificity of MPI was
ower than WMA. An abnormal MPI study correctly
dentified 173 of the 180 patients with CAD by quantitative
oronary angiography and failed to identify 7 of them. On
he other hand, MPI was negative in 35 patients without
ngiographically significant CAD and positive in 34 pa-
ients. A positive wall motion study correctly identified 115
f the 180 patients with CAD by quantitative coronary
ngiography and failed to identify 65. Wall motion analysis
as negative in 50 patients without CAD and was positive
n 19. There were 58 patients (32%) with CAD who had no
MA and a positive MPI. The diagnostic accuracies of
MA and MPI for the detection of angiographically
igure 1. Proportions of patients who underwent dobutamine stress
eal-time contrast echocardiography without inducible abnormalities (dark
reas represent fixed abnormalities, white areas represent negative) (A)
nd with inducible abnormalities (dark areas represent fixed plus inducible
bnormalities, white areas represent inducible abnormalities) (B) by
nalysis of wall motion abnormalities (WMA) and myocardial perfusion
maging (MPI). Myocardial perfusion imaging identified a higher propor-
ion of patients with inducible abnormalities than WMA (32% vs. 17%;
 0.01) and a lower proportion of patients without inducible abnormal-
ties (68% vs. 83%; p  0.01).ignificant CAD are shown in Table 4.
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April 19, 2005:1235–42 Safety of Myocardial Contrast Perfusion Imagingeasibility of RTCE image interpretation. Among the
24 patients randomly chosen for determining the feasibility
f MPI, a total of 3,144 walls were evaluated both at
aseline and during dobutamine stress. The analysis of
ontrast-enhanced wall motion by RTCE was considered
easible in all these LV walls. Myocardial perfusion imaging
as deemed feasible in 2,949 (94%) walls and not feasible in
95 (6%) at baseline. Non-feasible images were obtained in
he lateral wall in 46 patients (9%), the anterior wall in 40
atients (8%), the posterior wall in 36 patients (7%), the
nferior wall in 26 patients (5%), the anteroseptal wall in 24
5%), and the septum in 23 patients (4%). At peak stress,
PI was feasible in 2,973 (95%) walls and not feasible in 171
5%) walls. Interpretation of perfusion was not feasible in the
ateral wall in 39 patients (7%), the anterior wall in 36 patients
7%), the posterior wall in 30 patients (6%), the inferior wall in
4 patients (5%), the anteroseptal wall in 22 (4%), and the
eptum in 20 patients (4%). The distribution of walls that were
ot feasible is illustrated in Figure 2. The anterior, lateral, and
osterior were the most common walls in which MPI was not
easible both at baseline and peak stress.
Among the 1,572 coronary artery territories analyzed, MPI
Table 2. Hemodynamic Data in RTCE and in
Variables
RTCE With Op
(n  963)
Baseline
HR (beats/min) 75  14
SBP (mm Hg) 143  27
DBP (mm Hg) 77  14
RPP (mm Hg/min) 10,647  2,89
Peak
HR (beats/min) 145  13
% predicted maximal HR 91  9
SBP (mm Hg) 142  36
DBP (mm Hg) 69  17
RPP (mm Hg/min) 20,387  5,96
Data are mean  SD. *p  0.05 by analysis of variance.
DBP  diastolic blood pressure; HR  heart rate; RPP
abbreviations as in Table 1.
Table 3. Adverse Effects Observed in RTCE a
Variables
RTCE W
(n
Arrhythmias
Premature ventricular complexes 21
Premature supraventricular complexes 5
Supraventricular tachycardia 1
Rate-dependent branch block
Atrial fibrillation/flutter 2
Nonsustained ventricular tachycardia 1
Sustained ventricular tachycardia
Sustained arrhythmias* 4
Chest pain in abnormal tests 62/34
Chest pain in normal tests 15/61
Hypotension 11
Hypertension 1
Dyspnea 1
Data are number (%) of patients. *Sustained arrhythmias in
sustained ventricular tachycardia.
Abbreviations as in Table 1.as deemed feasible in 1,484 (94%) and not feasible in 88
erritories (6%) at baseline. The left anterior descending coro-
ary artery territory had the highest feasibility of interpretation
96% of patients), whereas the left circumflex territory was
easible in 94% of patients and the right coronary artery
erritory in 94% of patients. At peak stress, 1,496 (95%) of
oronary artery territories were deemed feasible and 76 (5%)
erritories were not feasible. The feasibility was 96% for the left
nterior descending coronary artery, 94% for left circumflex,
nd 95% for right coronary artery territories. There was no
ignificant difference in the feasibility of MPI interpretation
etween baseline and stress conditions.
ISCUSSION
eal-time contrast echocardiography has the potential to
mage myocardial perfusion and wall motion simultaneously
fter intravenous injections of ultrasound contrast agents at
he same doses approved by the FDA for LV opacification.
ecent studies have found that MPI with RTCE is a useful
echnique for the detection of CAD during both dobut-
mine and dipyridamole stress testing (7,9,10). Neverthe-
ventional DSE
RTCE With Definity
(n  523)
DSE
(n  1,012)
75  13 73  13*
148  27 144  25*
79  13 78  13
11,081  2,747 10,543  2,661*
147  10 145  14
91  9 92  9
144  37 142  34
71  18 70  17
20,837  6,288 20,589  5,294
te-pressure product; SBP  systolic blood pressure; other
Conventional DSE
ptison
)
RTCE With Definity
(n  523)
DSE
(n  1,012)
7%) 129 (24.7%) 258 (25.5%)
%) 19 (3.6%) 48 (4.7%)
%) 5 (1.0%) 19 (1.9%)
%) 3 (0.6%) 8 (0.8%)
%) 8 (1.5%) 15 (1.5%)
%) 6 (1.1%) 8 (0.8%)
%) 0 3 (0.2%)
%) 21 (4.0%) 37 (3.6%)
9%) 19/144 (13.2%) 26/153 (16.9%)
%) 9/379 (2.3%) 17/859 (2.0%)
7%) 74 (14.1%) 127 (12.5%)
%) 12 (2.3%) 15 (1.5%)
%) 8 (1.5%) 27 (2.6%)
supraventricular tachycardia, atrial fibrillation/flutter, andCon
tison
2
4nd in
ith O
 963
9 (22.
2 (5.4
6 (1.7
6 (0.6
0 (2.1
4 (1.4
5 (0.5
1 (4.2
6 (17.
7 (2.4
5 (11.
5 (1.5
7 (1.8
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Safety of Myocardial Contrast Perfusion Imaging April 19, 2005:1235–42ess, contrast agents are not yet approved by the FDA for
he evaluation of myocardial perfusion, and data regarding
he safety of MPI with dobutamine stress RTCE have been
imited. Therefore, in the current study we assessed the
afety and feasibility of MPI in a large number of patients
ho underwent dobutamine stress RTCE. With this low
echanical index imaging technique, we did not observe an
ncreased incidence of adverse complications, and the fea-
ibility for regional evaluation of myocardial perfusion was
90% both at baseline and at peak stress.
ncidence of adverse effects during dobutamine stress.
e observed that the incidence of arrhythmias and other
inor adverse effects with RTCE was similar to that
bserved in patients examined during the same period with
onventional DSE. The lack of increased propensity for
rrhythmias using RTCE in conjunction with dobutamine
tress might be related to the lower mechanical index used
or imaging microbubbles, which is known to reduce the
isk for cavitation. The bioeffects of microbubble cavitation
y ultrasound scanning have been shown in vitro and in vivo
11,18,19). There is some evidence that the intravenous
njection of contrast agents is associated with induction of
remature ventricular depolarizations when using a high
echanical index ultrasound scan. One study using intra-
enous contrast agents has reported an increased number of
VC when applying end-systolic–triggered imaging at a
echanical index of 1.5 (13). The induction of arrhythmias
as related to both the dose of contrast agent and the
coustic pressure studied. Although we gave intravenous
Table 4. Diagnostic Parameters of MPI and W
Significant Coronary Artery Disease
W
Sensitivity 115/180; 64
Specificity 50/69; 72
Positive predictive value 115/134; 86
Negative predictive value 50/115; 43
Accuracy 165/249; 66
Results are number; percent of patients (corresponding 9
abnormalities (WMA).
MPI  myocardial perfusion imaging; other abbreviationigure 2. Distribution of the left ventricular walls in which the myocardial perfus
he lateral, anterior, and posterior walls were the most frequently considered aolus injections of microbubbles that create transient high
oncentrations of microbubbles in the LV cavity and imaged
hroughout the cardiac cycle, the low mechanical index
ulse sequence scheme (0.3) did not produce a significant
ncrease in PVC. The most likely reason for this was the
ower number of microbubbles being destroyed at this
echanical index.
It is possible that one would see a greater incidence of
rrhythmias had we used a higher mechanical index impulse
uring the catecholamine stress in this situation (20). To date,
here are no data showing this with dobutamine. However,
igh mechanical index–triggered ultrasound scanning has been
sed with vasodilator stress without an increased incidence of
rrhythmias. Raisinghani et al. (21) reported no increase in the
umber of PVC in patients undergoing imaging with triggered
ltrasound scanning at a high mechanical index during dipy-
idamole stress.
The other adverse effects of dobutamine stress are related
o the intense sympathomimetic stimulation. These include
ypertension, chest pain, and shortness of breath. The
ncidence of these side effects was also not higher in the
resence of intravenous ultrasound contrast agents when
ompared with the conventional DSE protocol. Although
here have been concerns about myocardial necrosis being
nduced by ultrasound-mediated microbubble destruction,
e did not observe any increased incidence of chest pain in
he abnormal studies, and there was no incidence of myo-
ardial infarction or death.
by RTCE for Detecting Angiographically
MPI
%–71%) 173/180; 96% (93%–99%)*
%–83%) 35/69; 51% (39%–63%)*
%–92%) 173/207; 84% (79%–89%)
%–72%) 35/42; 83% (78%–88%)*
%–72%) 208/249; 84% (79%–88%)*
nfidence intervals). *p  0.05 compared to wall motion
Table 1.MA
MA
% (57
% (62
% (80
% (60
% (60
5% coion imaging was considered not feasible both at baseline and at peak stress.
s not feasible.
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April 19, 2005:1235–42 Safety of Myocardial Contrast Perfusion Imagingeasibility of MPI image interpretation. Our results
how that RTCE was able to assess myocardial perfusion in
5% of LV walls during dobutamine infusion and 94%
nder resting conditions. Because of the lateral resolution of
he ultrasound beam, the lateral wall was the most common
all in which the analysis of MPI was considered not
easible. Furthermore, the basal segments of LV walls are
ore susceptible to have contrast attenuation or poor
ontrast signal. For this reason, when only these segments
ere not adequately evaluated, we used the contrast en-
ancement in the mid and apical segments to perform the
nalysis of MPI in that specific ventricular wall. Using this
ethodology, feasibility was high, and diagnostic accuracy
as excellent.
The use of intravenous contrast agents has been shown to
mprove the assessment of segmental wall motion and
nterobserver agreement by enhancing the endocardial bor-
er delineation (22,23). Because RTCE permits the analysis
f both wall motion and perfusion, the injection of contrast
gents during RTCE should also assist in detecting WMA.
undley et al. (24) have shown that the analysis of lateral
all during stress was possible in 81% of cases without
ontrast, and this rate increased to 99% after the addition of
ontrast for endocardial border delineation. We also found
hat the analysis of wall motion was feasible in all walls in
he presence of contrast.
tudy limitations. Recently, the combination of intrave-
ous contrast agents and RTCE with application of high
echanical index impulses for microbubble destruction
ollowed by myocardial replenishment has allowed for the
uantification of myocardial blood flow (9,25). The effect of
hese high mechanical index impulses on the incidence of
rrhythmias was not addressed in our study.
Because the coronary angiography was performed at the
iscretion of the referring physician, we do recognize that
he diagnostic accuracy of RTCE was evaluated in a biased
roup of patients. The results of the stress test probably
nfluenced the indication for coronary angiography, result-
ng in the observed high prevalence of CAD in our study
opulation. Although we have shown that perfusion as-
essed with RTCE has improved sensitivity in this selected
roup of patients, larger prospective studies will be required
o examine both the diagnostic accuracy and prognostic
alue of MPI over wall motion analysis during DSE.
ONCLUSIONS
obutamine stress RTCE is a safe and feasible test for the
valuation of patients with known or suspected CAD. In a
arge patient population, we observed no increased inci-
ence of major side effects or arrhythmias when using
ntravenous ultrasound contrast and low mechanical index
eal-time perfusion imaging. Myocardial perfusion imaging
uring RTCE, therefore, may add incremental value in
etecting CAD without increasing risk.eprint requests and correspondence: Dr. Thomas R. Porter,
niversity of Nebraska Medical Center, 981165 Nebraska Medical
enter, Omaha, Nebraska 68198-1165. E-mail: trporter@unmc.edu.
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